Hospitals, rehabilitation centers and senior citizens’ homes are all facing considerable challenges in an era of shifting parameters. Although these institutions stand to profit from prevailing demographic trends, the same trends are necessitating well-tuned strategies to get a grip on changes in hospital funding, DRGs and systems of payment.

 

In the world of pharmaceutical R&D, the name of the game is early evaluation of NCEs on their way down the product pipeline. Other topics are time to market, intelligent pricing and market management. Medium-sized pharmaceutical companies also need to master the challenges posed by generic medications.

 

For valuable insight and orientation, turn to the Health Care Competence Center.

 

 health@taeger.de